Phase II Trial of Molecularly Determined Treatment of Children and Young Adults With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
Phase of Trial: Phase II
Latest Information Update: 24 Jul 2018
At a glance
- Drugs Bevacizumab (Primary) ; Erlotinib (Primary) ; Temozolomide (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 17 Jul 2018 Status changed from active, no longer recruiting to completed.
- 25 Jul 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.
- 19 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.